About Sapna Srivastava
Form D filings for AsclepiX Therapeutics from 2019 to 2024 list Sapna Srivastava as director.
Sapna Srivastava first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Sapna Srivastava in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sapna Srivastava works with at each company, as listed on that company's latest Form D.
AsclepiX Therapeutics, Inc. · Form D, Apr 26, 2024
RD
Robert Dempsey
Chief Executive Officer
Steven Altschuler
Director
BA
Ben Askew
Director
JB
Josh Barer
Director
CG
Chris Garabedian
Director
AP
Aleksander Popel
Executive officer
AS
Amir Shojaei
Executive officer
NP
Niranjan Pandey
Executive officer
JT
Jill Tierney
Executive officer
JG
Jordan Green
Director